Eupnoos is a health-tech company developing AI-powered digital tools for cardiorespiratory health and drug safety monitoring. Our proprietary audio-phenotyping platform transforms any smartphone into a clinically-validated device that can analyse breath sounds in seconds to detect signs of airway obstruction, restriction, or pulmonary congestion.

Beyond respiratory disease detection, Eupnoos is pioneering the use of acoustic biomarkers to **monitor cardiopulmonary adverse events in cancer therapy — helping clinicians and pharma partners identify early signs of drug-induced lung injury (DIILD), pneumonitis, or heart failure before they become severe.

Our mission is to make advanced respiratory and safety monitoring affordable, accessible, and continuous** — empowering patients and healthcare providers to detect problems early, improve outcomes, and reduce avoidable hospitalisations.

Eupnoos

Org chart

Teams

Offices